XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Statements of Stockholders Equity/(Deficit) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Dec. 31, 2022 $ 5 $ 352,828 $ (348,823) $ 51 $ 4,061
Balance (in shares) at Dec. 31, 2022 48,063,358        
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options (in shares)         0
Restricted Stock Units released for common stock issued under Equity Incentive Plan (in shares) 50,203        
Stock-based compensation expense   2,055     $ 2,055
Net Income (Loss)     (10,137)   (10,137)
Other comprehensive income (loss)       $ (51) (51)
Balance at Mar. 31, 2023 $ 5 354,883 (358,960)   (4,072)
Balance (in shares) at Mar. 31, 2023 48,113,561        
Balance at Dec. 31, 2023 $ 8 451,432 (468,586)   (17,146)
Balance (in shares) at Dec. 31, 2023 84,869,832        
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock and prefunded warrants, net of issuance costs of $8.2 million $ 2 104,746     104,748
Issuance of common stock and prefunded warrants, net of issuance costs of $8.2 million (in shares) 15,285,714        
Exercise of common warrants $ 1 61,217     61,218
Exercise of common warrants (in shares) 9,025,000        
Exercise of pre-funded warrants (in shares) 4,206,285        
Exercise of stock options   33     $ 33
Exercise of stock options (in shares) 32,290       32,290
Restricted Stock Units released for common stock issued under Equity Incentive Plan (in shares) 822,682        
Stock-based compensation expense   2,379     $ 2,379
Net Income (Loss)     (83,938)   (83,938)
Balance at Mar. 31, 2024 $ 11 $ 619,807 $ (552,524)   $ 67,294
Balance (in shares) at Mar. 31, 2024 114,241,803